Related Experiment Video
Updated: Aug 7, 2026

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
Cholinergic overstimulation supports conditioned-facilitated startle but not conditioned hyperalgesia
Kevin D Beck1, Michele Hsu, Xilu Jiao
1Neurobehavioral Research Laboratory (129), Department of Veterans Affairs New Jersey Health Care System, East Orange, NJ 07018, USA. beck@njneuromed.org
Pyridostigmine bromide (PB) enhances startle responses but does not affect pain reflexes. This suggests PB
Area of Science:
- Neuroscience
- Behavioral Pharmacology
Background:
- Pyridostigmine bromide (PB) is a cholinesterase inhibitor known to influence learned associations.
- Previous research indicates PB can potentiate startle responses to odors in rats.
Purpose of the Study:
- To further characterize the learning parameters of the odor-PB association.
- To determine if PB's effects extend to other behavioral responses, such as the thermal pain reflex.
Main Methods:
- Rats were trained to associate an odor with PB administration.
- Startle reactivity and paw-lick latency (thermal pain reflex) were measured following odor exposure.
- The duration of PB's effect on startle and its influence on the pain reflex were assessed.
Main Results:
- Acute PB administration temporarily increased startle reactivity (lasting <2 hours).
- The conditioned enhancement of startle response to the odor lasted less than 4 weeks.
- PB did not affect the latency to paw-lick in response to thermal pain, nor did the associated odor elicit changes in this reflex.
Conclusions:
- The effects of pyridostigmine bromide as a conditioned stimulus are specific to certain behaviors.
- PB's action as an unconditioned stimulus primarily influences startle-related behaviors, not nociceptive reflexes.
- Future research on PB and conditions like Gulf War Illness should focus on behaviors modulated by peripheral cholinergic activity.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...

